Cutaneous melanoma at the Turin Melanoma Center. I. Survival and correlation with clinical and histologic prognostic factors in 502 patients in stage I (1975-1985)
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Pippione, M.; Aloi, F.G.; Stuardi, C.; Zina, G.
Giornale Italiano di Dermatologia e Venereologia Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 121(5): 311-326
1986
ISSN/ISBN: 0392-0488 PMID: 3793141 Document Number: 267801
Document emailed within 1 workday
Related Documents
Bernengo, M.G.; Doveil, G.C.; Lisa, F.; Stuardi, C.; Zina, G. 1987: Cutaneous melanoma at the Turin Melanoma Center. II. Risk of metastasis and free interval in relation to the clinical and histological prognostic factors in 502 patients in stage I (1975-1985) Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 122(4): 143-153Di Filippo, F.; Giacomini, P.; Rossi, C.R.; Santinami, M.; Anzà, M.; Garinei, R.; Perri, P.; Botti, C.; Di Angelo, P.; Sofra, C.; Pasqualoni, R.; Sperduti, I.; Cavaliere, F.; Di Filippo, S.; Corrias, F.; Armenti, A.; Ferraresi, V.; Ginebri, A. 2009: Prognostic factors influencing tumor response, locoregional control and survival, in melanoma patients with multiple limb in-transit metastases treated with TNFalpha-based isolated limb perfusion In Vivo 23(2): 347-352
Uehara, S.; Kamo, R.; Harada, T.; Ishii, M. 2009: Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors Osaka City Medical Journal 55(1): 35-52
Ohta, H.; Shioji, K.; Maruyama, Y.; Watanabe, K.; Aiba, T.; Baba, Y.; Seki, K.; Yanagi, M.; Iiri, T.; Ishizuka, K.; Isokawa, O.; Nakamura, A.; Natsui, M.; Furukawa, K.; Suzuki, Y.; Ban-Nai, H.; Motoyama, N.; Mori, S.; Aoyagi, Y. 2008: Gemcitabine treatment in patients with stage IV pancreatic cancer and prognostic factors for survival of patients with stage IVb(a retrospective survey at 15 hospitals in Niigata Prefecture) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(13): 2357-2361
Day, C.L.; Sober, A.J.; Kopf, A.W.; Lew, R.A.; Mihm, M.C.; Golomb, F.M.; Hennessey, P.; Harris, M.N.; Gumport, S.L.; Raker, J.W.; Malt, R.A.; Cosimi, A.B.; Wood, W.C.; Roses, D.F.; Gorstein, F.; Fitzpatrick, T.B.; Postel, A. 1981: A prognostic model for clinical stage i melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease Surgery 89(5): 599-603
Jonk, A.; Kroon, B.B. 1990: The effects of negative regional lymph-node dissection on survival and disease-free interval of patients with stage-I malignant melanoma Netherlands Journal of Surgery 42(6): 161-162
Nepomniashchaia, E.M.; Gusareva, M.A.; Petrov, S.V. 2008: Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities Voprosy Onkologii 54(6): 744-748
Ingkaninanda, P.; Visessiri, Y.; Rutnin, S. 2015: Clinicopathological Features and Prognostic Factors of Malignant Melanoma: A Retrospective Analysis of Thai Patients in Ramathibodi Hospital Journal of the Medical Association of Thailand 98(8): 820-827
Green, M.S. 1991: The changing controversy over surgical resection margins for stage I cutaneous melanoma Mount Sinai Journal of Medicine new York 58(4): 341-346
Miura, T.; Ishikawa, S. 1970: Malignant melanoma--synopses from the seminar on malignant melanoma by International Group for the Clinical Study of Melanoma Gan no Rinsho. Japan Journal of Cancer Clinics 16(11): 1064-1070
Avilés, J.A.; Lázaro, P.; Lecona, M. 2006: Epidemiology and survival of cutaneous melanoma in Spain: a report of 552 cases (1994-2003) Revista Clinica Espanola 206(7): 319-325
Przywara, S.; Niepołomska, W.; Adamus, J. 1978: Various prognostic factors in malignant melanoma Polski Przeglad Chirurgiczny 50(12): 1049-1055
Volkenandt, M.; Schmidt, M.; Konz, B.; Gummer, M.; Hein, R.; Plewig, G.; Hölzel, D. 1999: Clinical and epidemiological data of patients with malignant melanoma from the Munich Tumor Center 1977-1997 Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 50(7): 470-478
Dixon, A. 2006: Melanoma with cutaneous melanoma secondaries Australian Family Physician 35(11): 871-872
Caracò, C.; Chiofalo, M.G.; Niro, J.; Ascierto, P.A.; Botti, G.; Lastoria, S.; Mozzillo, N. 2002: Sentinel lymph node biopsy to stage patients with cutaneous melanoma at the National Cancer Institute of Naples. Results from 240 sentinel node biopsies Tumori 88(3): S12-S13
Shannan, B.; Seifert, M.; Leskov, K.; Boothman, D.; Pföhler, C.; Tilgen, W.; Reichrath, J. 2006: Clusterin (CLU) and melanoma growth: CLU is expressed in malignant melanoma and 1,25-dihydroxyvitamin D3 modulates expression of CLU in melanoma cell lines in vitro Anticancer Research 26(4a): 2707-2716
Holly, E.A.; Weiss, N.S.; Liff, J.M. 1983: Cutaneous melanoma in relation to exogenous hormones and reproductive factors Journal of the National Cancer Institute 70(5): 827-831
Bourlond, A. 1971: Multiple juvenile melanoma. Clinical observations with histologic and electron microscopic studies Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 22(4): 144-149
Avril, M.-F.ço. 2004: Clinical aspects of cutaneous melanoma: atlas La Revue du Praticien 54(11): 1187-1192
Balch, C.M. 1987: Cutaneous melanoma: a review of clinical management Texas Medicine 83(3): 70-78